SynapDx
SynapDx, Broad Collaborate on NGS Analysis Methods for ASD Diagnostics
NEW YORK (GenomeWeb News) – SynapDx today announced a collaboration with the Broad Institute to develop next-generation sequencing analysis methods to improve autism diagnostics.
Foundation Medicine, Quanterix among Omics Firms Getting Massachusetts Tax Incentives
NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has released the list of firms that will receive a total of $25 million in tax incentives tied to job creation this year, and that list includes several omics and molecular diagnostics firms.
Paired Ends: Kevin Hrusovsky
Premium
SynapDx has appointed Kevin Hrusovsky to the firm's board of directors. He most recently served as president of life sciences and technology at PerkinElmer.
SynapDx said this week that Mark DePristo has joined the Lexington, Mass.-based company as vice pres
Illumina has appointed Richard Klausner to senior vice president and Chief Medical Officer, where he will lead Illumina's strategies for advancing genomics into clinical medicine and public health.
Sep 24, 2013
Jul 23, 2013
Jul 22, 2013
SynapDx Raises $15.4M
Mar 6, 2013
Illumina, SynapDx Join Forces on ASD
Jun 30, 2010
Pairings: Jun 30, 2010
Premium
Jun 1, 2010